Management of hyperglycemia during enteral and parenteral nutrition therapy

Current Diabetes Reports

Volumn 13, Issue 1, 2013, Pages 155-162

  Gosmanov, Aidar R ^a   Umpierrez, Guillermo E ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes mellitus; Enteral nutrition; Hyperglycemia; Insulin; Nutrition support; Parenteral nutrition

Indexed keywords

ALANINE; BIPHASIC INSULIN; BIPHASIC INSULIN 70 30; CHROMIUM; GLUCOCORTICOID; GLUCOSE; GLUTAMINE; HYPERTENSIVE FACTOR; INSULIN; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; LIPID EMULSION; LONG ACTING INSULIN; OLIVE OIL; OMEGA 6 FATTY ACID; SHORT ACTING INSULIN; SLIDING SCALE REGULAR INSULIN; SOYBEAN OIL; UNCLASSIFIED DRUG;

ARTICLE; ASPIRATION PNEUMONIA; CARBOHYDRATE INTAKE; COMORBIDITY; CONTINUOUS INFUSION; COST EFFECTIVENESS ANALYSIS; CRITICALLY ILL PATIENT; DEATH; DIABETES MELLITUS; DIARRHEA; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG OVERDOSE; DRUG SAFETY; ENTERIC FEEDING; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOGLYCEMIA; INFECTION RISK; INFUSION RATE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KIDNEY FAILURE; LOW DRUG DOSE; MACRONUTRIENT; MALNUTRITION; MORTALITY; NAUSEA; OVERNUTRITION; PARENTERAL NUTRITION; PATHOPHYSIOLOGY; PREVALENCE; STOMACH ATROPHY; TOTAL PARENTERAL NUTRITION;

DIET; ENTERAL NUTRITION; HUMANS; HYPERGLYCEMIA; INSULIN; PARENTERAL NUTRITION;

EID: 84872528393     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-012-0335-y     Document Type: Article

References (81)

1. •• Umpierrez GE, Hellman R, Korytkowski MT, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:16-38. These guidelnies represent the most up to date recommendations on management of hyperglycemia in hospitalized non-critically ill patients.
2. Cook CB, Kongable GL, Potter DJ, et al. Inpatient glucose control: a glycemic survey of 126 U.S. hospitals. J Hospital Med. 2009;4:E7-E14.
3. Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978-82. (Pubitemid 36121050)
4. Jiang HJ, Stryer D, Friedman B, Andrews R. Multiple hospitalizations for patients with diabetes. Diabetes Care. 2003;26:1421-6. (Pubitemid 36929173)
5. Pleva M, Mirtallo JM, Steinberg SM. Hyperglycemic events in non-intensive care unit patients receiving parenteral nutrition. Nutr Clin Pract. 2009;24:626-34.
6. Rosmarin DK, Wardlaw GM, Mirtallo J. Hyperglycemia associated with high, continuous infusion rates of total parenteral nutrition dextrose. Nutr Clin Pract. 1996;11:151-6.
7. Arinzon Z, Shabat S, Shuval I, et al. Prevalence of diabetes mellitus in elderly patients received enteral nutrition long-term care service. Arch Gerontol Geriatr. 2008;47:383-93.
8. Pancorbo-Hidalgo PL, Garcia-Fernandez FP, Ramirez-Perez C. Complications associated with enteral nutrition by nasogastric tube in an internal medicine unit. J Clin Nurs. 2001;10:482-90. (Pubitemid 33754775)
9. Baum D, Porte Jr D. Stress hyperglycemia and the adrenergic regulation of pancreatic hormones in hypoxia. Metabolism. 1980;29:1176-85. (Pubitemid 11166198)
10. Ortiz-Alonso FJ, Herman WH, Zobel DL, et al. Effect of epinephrine on pancreatic beta-cell and alpha-cell function in patients with NIDDM. Diabetes. 1991;40:1194-202.
11. Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009;373:1798-807.
12. Gosmanov AR, Umpierrez GE. Medical nutrition therapy in hospitalized patients with diabetes. Curr Diab Rep. 2012;12:93-100.
13. McCowen KC, Bistrian BR. Hyperglycemia and nutrition support: theory and practice. Nutr Clin Pract. 2004;19:235-44. (Pubitemid 38747821)
14. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin. 2001;17:107-24. (Pubitemid 32163181)
15. Alibegovic AC, Hojbjerre L, Sonne MP, et al. Impact of 9 days of bed rest on hepatic and peripheral insulin action, insulin secretion, and whole-body lipolysis in healthy young male offspring of patients with type 2 diabetes. Diabetes. 2009;58:2749-56.
16. Bienso RS, Ringholm S, Kiilerich K, et al. GLUT4 and Glycogen Synthase are key players in bed rest-induced insulin resistance. Diabetes. 2012;61:1090-9.
17. Ljungqvist O. Jonathan E. Rhoads Lecture 2011: insulin resistance and enhanced recovery after surgery. JPEN. J Parenter Enteral Nutr. 2012;36:389-98.
18. Preiser JC. Glycemic control and nutrition. JPEN. Journal of Parenteral and Enteral. Nutrition. 2011;35:671-2.
19. Valero MA, Leon-Sanz M, Escobar I, et al. Evaluation of nonglucose carbohydrates in parenteral nutrition for diabetic patients. Eur J Clin Nutr. 2001;55:1111-6. (Pubitemid 33114685)
20. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67:352-60. discussion 360-352. (Pubitemid 29176984)
21. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-67.
22. Umpierrez GE, Smiley D, Jacobs S, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011;34:256-61.
23. Cheung NW, Napier B, Zaccaria C, Fletcher JP. Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition. Diabetes Care. 2005;28:2367-71. (Pubitemid 41384278)
24. Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27:553-91. (Pubitemid 38174086)
25. •• Korytkowski MT, Salata RJ, Koerbel GL, et al. Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care. 2009;32:594-6. The only randomized controlled trial comparing different insulin regimens in managing hyperglycemia in patients receiving enteral nutrition therapy.
26. • Ziegler TR. Parenteral nutrition in the critically ill patient. N Engl J Med. 2009;361:1088-97. State-of-the-art review article describing current evidence for the use of TPN in the hospitalized patients.
27. Pasquel FJ, Spiegelman R, McCauley M, et al. Hyperglycemia during total parenteral nutrition: an important marker of poor outcome and mortality in hospitalized patients. Diabetes Care. 2010;33:739-41.
28. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009;15:353-69.
29. Mesotten D, Van den Berghe G. Glycemic targets and approaches to management of the patient with critical illness. Curr Diab Rep. 2012;12:101-7.
30. • Marik PE, Preiser JC. Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis. Chest. 2010;137:544-51. This meta-analysis suggests that glycemic targets for the patients in ICU receiving parenteral nutrition can be lower than in other crictically ill patients.
31. Sarkisian S, Fenton TR, Shaheen AA. Raman M [Parenteral nutrition-associated hyperglycemia in noncritically ill inpatients is associated with higher mortality. Canadian journal of gastroenterology]. Journal Canadien de Gastroenterologie. 2010;24:453-7.
32. Lin LY, Lin HC, Lee PC, et al. Hyperglycemia correlates with outcomes in patients receiving total parenteral nutrition. Am J Med Sci. 2007;333:261-5. (Pubitemid 46787953)
33. Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit vs harm. Diabetes. 2006;55:3151-9. (Pubitemid 44923655)
34. Cresci G. Targeting the use of specialized nutritional formulas in surgery and critical care. JPEN; J Parenter Enteral Nutr. 2005;29:S92-5.
35. McMahon MM, Rizza RA. Nutrition support in hospitalized patients with diabetes mellitus. Mayo Clin Proc. 1996;71:587-94.
36. Bantle JP, Wylie-Rosett J, Albright AL, et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008;31 Suppl 1:S61-78.
37. McClave SA, Martindale RG, Vanek VW, et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN; J Parenter Enteral Nutr. 2009;33:277-316.
38. Anderson AD, Palmer D, MacFie J. Peripheral parenteral nutrition. Br J Surg. 2003;90:1048-54. (Pubitemid 37152161)
39. Heyland DK, Montalvo M, MacDonald S, et al. Total parenteral nutrition in the surgical patient: a meta-analysis. Can J Surg. 2001;44:102-11. (Pubitemid 32422708)
40. Bellantone R, Doglietto GB, Bossola M, et al. Preoperative parenteral nutrition in the high risk surgical patient. JPEN; J Parenter Enteral Nutr. 1988;12:195-7. (Pubitemid 18087296)
41. Kreymann KG, Berger MM, Deutz NE, et al. ESPEN Guidelines on enteral nutrition: intensive care. Clin Nutr. 2006;25:210-23. (Pubitemid 43811686)
42. Florian JP, Pawelczyk JA. Non-esterified fatty acids increase arterial pressure via central sympathetic activation in humans. Clin Sci. 2010;118:61-9.
43. Craig LD, Nicholson S, Silverstone FA, Kennedy RD. Use of a reduced-carbohydrate, modified-fat enteral formula for improving metabolic control and clinical outcomes in long-term care residents with type 2 diabetes: results of a pilot trial. Nutrition. 1998;14:529-34. (Pubitemid 28285290)
44. Leon-Sanz M, Garcia-Luna PP, Sanz-Paris A, et al. Glycemic and lipid control in hospitalized type 2 diabetic patients: evaluation of 2 enteral nutrition formulas (low carbohydrate-high monounsaturated fat vs high carbohydrate). JPEN; J Parenter Enteral Nutr. 2005;29:21-9.
45. Elia M, Ceriello A, Laube H, et al. Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes: a systematic review and meta-analysis. Diabetes Care. 2005;28:2267-79. (Pubitemid 41242484)
46. Alish CJ, Garvey WT, Maki KC, et al. A diabetes-specific enteral formula improves glycemic variability in patients with type 2 diabetes. Diabetes Technol Ther. 2010;12:419-25.
47. Vaisman N, Lansink M, Rouws CH, et al. Tube feeding with a diabetes-specific feed for 12 weeks improves glycaemic control in type 2 diabetes patients. Clin Nutr. 2009;28:549-55.
48. Pohl M, Mayr P, Mertl-Roetzer M, et al. Glycemic control in patients with type 2 diabetes mellitus with a disease-specific enteral formula: stage II of a randomized, controlled multicenter trial. JPEN; J Parenter Enteral Nutr. 2009;33:37-49.
49. Pohl M, Mayr P, Mertl-Roetzer M, et al. Glycaemic control in type II diabetic tube-fed patients with a new enteral formula low in carbohydrates and high in monounsaturated fatty acids: a randomised controlled trial. Eur J Clin Nutr. 2005;59:1221-32. (Pubitemid 41655626)
50. Yokoyama J, Someya Y, Yoshihara R, Ishii H. Effects of high-monounsaturated fatty acid enteral formula vs high-carbohydrate enteral formula on plasma glucose concentration and insulin secretion in healthy individuals and diabetic patients. J Int Med Res. 2008;36:137-46. (Pubitemid 351255979)
51. Charney P, Hertzler SR. Management of blood glucose and diabetes in the critically ill patient receiving enteral feeding. Nutr Clin Pract. 2004;19:129-36. (Pubitemid 38401853)
52. Umpierrez GE. Basal vs sliding-scale regular insulin in hospitalized patients with hyperglycemia during enteral nutrition therapy. Diabetes Care. 2009;32:751-3.
53. Fatati G, Mirri E, Del Tosto S, et al. Use of insulin glargine in patients with hyperglycaemia receiving artificial nutrition. Acta Diabetol. 2005;42:182-6. (Pubitemid 43029838)
54. Cook A, Burkitt D, McDonald L, Sublett L. Evaluation of glycemic control using NPH insulin sliding scale vs insulin aspart sliding scale in continuously tube-fed patients. Nutrition in Clinical Practice: official publication of the American Society for Parenteral and Enteral Nutrition. 2009;24:718-22.
55. Hsia E, Seggelke SA, Gibbs J, et al. Comparison of 70/30 biphasic insulin with glargine/lispro regimen in non-critically ill diabetic patients on continuous enteral nutrition therapy. Nutrition in Clinical Practice: official publication of the American Society for Parenteral and Enteral Nutrition. 2011;26:714-7.
56. Umpierrez GE, Jones S, Smiley D, et al. Insulin analogs vs human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial. Diabetes Care. 2009;32:1164-9.
57. Detsky AS, Baker JP, O'Rourke K, Goel V. Perioperative parenteral nutrition: a meta-analysis. Ann Intern Med. 1987;107:195-203. (Pubitemid 17137855)
58. Muller JM, Brenner U, Dienst C, Pichlmaier H. Preoperative parenteral feeding in patients with gastrointestinal carcinoma. Lancet. 1982;1:68-71. (Pubitemid 12248647)
59. Quigley EM, Marsh MN, Shaffer JL, Markin RS. Hepatobiliary complications of total parenteral nutrition. Gastroenterology. 1993;104:286-301. (Pubitemid 23040035)
60. Schutz Y, Thiebaud D, Acheson KJ, et al. Thermogenesis induced by five different intravenous glucose/insulin infusions in healthy young men. Clin Nutr. 1983;2:93-6. (Pubitemid 14216635)
61. Askanazi J, Weissman C, Rosenbaum SH, et al. Nutrition and the respiratory system. Crit Care Med. 1982;10:163-72.
62. Singer P, Berger MM, Van den Berghe G, et al. ESPEN Guidelines on Parenteral Nutrition: intensive care. Clin Nutr. 2009;28:387-400.
63. Via MA, Mechanick JI. Inpatient enteral and parental nutrition for patients with diabetes. Curr Diab Rep. 2011;11:99-105.
64. Ahrens CL, Barletta JF, Kanji S, et al. Effect of low-calorie parenteral nutrition on the incidence and severity of hyperglycemia in surgical patients: a randomized, controlled trial. Crit Care Med. 2005;33:2507-12. (Pubitemid 41682102)
65. Lee H, Koh SO, Park MS. Higher dextrose delivery via TPN related to the development of hyperglycemia in nondiabetic critically ill patients. Nutr Res Pract. 2011;5:450-4.
66. •• Casaer MP, Mesotten D, Hermans G, et al. Early vs late parenteral nutrition in critically ill adults. N Engl J Med. 2011;365:506-17. The results of this prospective randomized trial demonstrate new standards of nutrition initiation in hospitalized patients requiring parenteral nutrition.
67. Lidder P, Flanagan D, Fleming S, et al. Combining enteral with parenteral nutrition to improve postoperative glucose control. Br J Nutr. 2010;103:1635-41.
68. Yaqoob P. Lipids and the immune response. Curr Opin Clin Nutr Metab Care. 1998;1:153-61. (Pubitemid 128539438)
69. Yaqoob P. Monounsaturated fatty acids in parenteral nutrition; evaluation of risks and benefits. Br J Nutr. 2005;94:867-8. (Pubitemid 43092414)
70. Buenestado A, Cortijo J, Sanz MJ, et al. Olive oil-based lipid emulsion's neutral effects on neutrophil functions and leukocyte-endothelial cell interactions. JPEN; J Parenter Enteral Nutr. 2006;30:286-96.
71. Garcia-de-Lorenzo A, Denia R, Atlan P, et al. Parenteral nutrition providing a restricted amount of linoleic acid in severely burned patients: a randomized double-blind study of an olive oil-based lipid emulsion vs medium/long-chain triacylglycerols. Br J Nutr. 2005;94:221-30. (Pubitemid 41357793)
72. Yaqoob P. Monounsaturated fats and immune function. Proc Nutr Soc. 1998;57:511-20. (Pubitemid 128737121)
73. Siqueira J, Smiley D, Newton C, et al. Substitution of standard soybean oil with olive oil-based lipid emulsion in parenteral nutrition: comparison of vascular, metabolic, and inflammatory effects. J Clin Endocrinol Metab. 2011;96:3207-16.
74. •• Umpierrez GE, Spiegelman R, Zhao V, et al. A double-blind, randomized clinical trial comparing soybean oil-based vs olive oil-based lipid emulsions in adult medical-surgical intensive care unit patients requiring parenteral nutrition. Crit Care Med. 2012;40:1792-8. This is the only trial that compared clinical outcomes betwenn ICU patients receiving soybean oil-based and olive oil-based parenteral nutrition.
75. Opara EC, Petro A, Tevrizian A, et al. L-glutamine supplementation of a high fat diet reduces body weight and attenuates hyperglycemia and hyperinsulinemia in C57BL/6J mice. J Nutr. 1996;126:273-9.
76. Grau T, Bonet A, Minambres E, et al. The effect of L-alanyl-L-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients. Crit Care Med. 2011;39:1263-8.
77. McMahon MM. Management of parenteral nutrition in acutely ill patients with hyperglycemia. Nutr Clin Pract. 2004;19:120-8. (Pubitemid 38401852)
78. Sajbel TA, Dutro MP, Radway PR. Use of separate insulin infusions with total parenteral nutrition. JPEN; J Parenter Enteral Nutr. 1987;11:97-9. (Pubitemid 17009529)
79. Hongsermeier T, Bistrian BR. Evaluation of a practical technique for determining insulin requirements in diabetic patients receiving total parenteral nutrition. JPEN; J Parenter Enteral Nutr. 1993;17:16-9. (Pubitemid 23028780)
80. Jakoby MG, Nannapaneni N. An insulin protocol for management of hyperglycemia in patients receiving parenteral nutrition is superior to ad hoc management. JPEN; J Parenter Enteral Nutr. 2012;36:183-8.
81. Bankhead R, Boullata J, Brantley S, et al. Enteral nutrition practice recommendations. JPEN; J Parenter Enteral Nutr. 2009;33:122-67.